封面
市場調查報告書
商品編碼
1214635

心電圖(ECG)設備的市場規模:各產品,各導程類型,各攜帶,各最終用途-COVID-19影響分析,產業分析,地區展望,成長性,競爭市場佔有率,預測(2023年~2032年)

Electrocardiogram (ECG) Devices Market Size, By Product, By Lead Type, By Portability, By End-use, Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2023 - 2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 310 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

全球心電圖(ECG)設備的市場規模,主要由於ECG設備的持續性技術性升級,到2032年大幅度擴大。

還有一般市民的健康受到高度關注,主要企業對研究開發舉措的投資增加,促進市場成長。

本報告提供全球心電圖(ECG)設備市場相關調查分析,市場分析,競爭情形,企業簡介等系統性資訊。

目錄

第1章 調查手法和範圍

  • 產業報道
  • 市場範圍和定義
  • 基本估計與工作
    • 資料收集
  • 預測參數
  • 在世界水準的COVID-19影響分析
  • 資料檢驗
  • 資料來源
    • 二級
    • 一級

第2章 摘要整理

  • 心電圖(ECG)設備產業的全方位的摘要(2018年~2032年)
    • 事業趨勢
    • 產品趨勢
    • 導程類型趨勢
    • 攜帶趨勢
    • 最終用途趨勢
    • 地區趨勢

第3章 心電圖(ECG)設備產業考察

  • 產業形勢(100萬美元)(2018年~2032年)
  • 產業的影響要素
    • 促進因素
    • 產業的潛在的風險、課題
  • 成長性分析
    • 各產品
    • 各導程
    • 各攜帶性
    • 各最終用途
  • COVID-19影響分析
  • 法規情形
    • 美國
    • 歐洲
  • 償付情境
  • 技術形勢
    • 今後的技術
  • 波特分析
  • PESTEL分析

第4章 競爭情形(2021年)

  • 簡介
  • 企業矩陣分析
  • 策略儀表板

第5章 心電圖(ECG)設備市場:各產品

  • 主要的產品趨勢
  • 心電圖診斷設備
    • 靜態心電圖
    • 壓力時心電圖
  • 心電圖(ECG)設備的監測
    • 心電圖監測
    • 置入式心臟監測
    • ECG遙測監測/心臟事件記錄器
    • 其他

第6章 心電圖(ECG)設備市場:各導程類型

  • 主要的導程類型趨勢
  • 1芯類型
  • 3芯類型
  • 6芯類型
  • 12芯類型
  • 其他

第7章 心電圖(ECG)設備市場:各攜帶性

  • 攜帶的主要趨勢
  • 可攜式設備
  • 非可攜式設備

第8章 心電圖(ECG)設備市場:各最終用途

  • 主要的最終用途趨勢
  • 醫院和診所
  • 診斷中心
  • 門診病人手術中心
  • 居家醫療
  • 其他

第9章 心電圖(ECG)設備市場:各地區

  • 主要地區趨勢
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 波蘭
    • 瑞士
    • 荷蘭
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
    • 印尼
  • 南美
    • 阿根廷
    • 巴西
    • 哥倫比亞
    • 墨西哥
  • 中東、非洲
    • 沙烏地阿拉伯
    • 南非
    • 以色列
    • 阿拉伯聯合大公國

第10章 企業簡介

  • AliveCor, Inc.
  • Allengers Medical Systems, Ltd.
  • Biotricity, Inc.
  • Bionet America, Inc.
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • BPL Medical Technologies
  • Cardioline S.P.A
  • Fukuda Denshi Co., Ltd.
  • GE Healthcare
  • Hill-Rom Holdings, Inc.(Baxter)
  • Koninklijke Philips N.V.
  • Medtronic plc
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Spacelabs Healthcare(OSI Systems, Inc.)
簡介目錄
Product Code: 5425

Electrocardiogram (ECG) Devices Market is anticipated to expand substantially through 2032, primarily owing to the ongoing technical upgradation in ECG devices. These innovations are expected to assist healthcare professionals in treating and diagnosing patients accurately.

Besides, ECG helps measure the rhythm and heart rate, axis of the heart, and state of myocardial muscle, preventing heart attacks by analyzing heart parameters during the initial stage. Increasing health concerns among the general populace will fuel the market demand.

The constantly surging adoption of mobile and telemetry cardiac monitors, along with the rising investments made by the key players in R&D initiatives to develop and innovate technologically advanced electrocardiogram (ECG) devices, will drive market growth.

For instance, Samsung has announced built-in ECGs in its Galaxy Watch Active 2 and newer smartwatches. Reportedly, the owners of Galaxy Watch 5 and Galaxy Watch 5 Pro in Malaysia can use the Samsung Health Monitor app on their smartphones to analyze their ECG and blood pressure, enabling them to diagnose heart-related issues earlier and consult a doctor for possible remedies.

Overall, the electrocardiogram (ECG) devices industry is segmented in terms of product, lead, portability, end-use, and region.

Based on the product, the monitoring ECG devices segment would witness strong demand during the forecast timeframe owing to advantages such as diagnosing heart problems, monitoring heart function, and recording the electrical activity of heart for a prolonged period. In addition, the constant innovations in monitoring devices resulting in the introduction of easy-to-use and convenient wearable products will further stimulate market growth.

In terms of the lead, the single lead type segment accounted for over 8.5% market share in 2022. The segment will register sturdy growth owing to the rising government initiatives to improve patient care through faster diagnosis. Besides, single-lead ECG monitoring is being increasingly favored for recording ECG with handheld or wearable devices, which will further bolster the market.

Considering the portability, the portable device segment will grow considerably through 2032 owing to the increasing adoption of ECG devices for patients, along with better accuracy and faster outcomes. In addition, the easy accessibility of data to the patient and the installation of the latest technology in products will boost the market demand.

Based on end-use, the hospitals & clinics segment accounted for over 51% market share in 2022. The segmental growth will be driven by the rising prevalence of cardiovascular diseases, resulting in increased demand for ECG devices in hospitals & clinics.

Regionally, the North America electrocardiogram devices industry registered over 33.5% market share in 2022 and will further expand through 2032. Supporting government initiatives, increasing awareness regarding early-stage disease diagnosis, and developing technologically advanced ECG will propel regional market growth during the estimated timeframe.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Industry coverage
  • 1.2 Market scope and definitions
  • 1.3 Base estimates and working
    • 1.3.1 Data collection
  • 1.4 Forecast parameters
  • 1.5 COVID-19 impact analysis at global level
  • 1.6 Data validation
  • 1.7 Data sources
    • 1.7.1 Primary
    • 1.7.2 Secondary
      • 1.7.2.1 Paid sources
      • 1.7.2.2 Unpaid sources

Chapter 2 Executive Summary

  • 2.1 Electrocardiogram (ECG) devices industry 360 degree synopsis, 2018 - 2032
    • 2.1.1 Business trends
    • 2.1.2 Product trends
    • 2.1.3 Lead type trends
    • 2.1.4 Portability trends
    • 2.1.5 End-use trends
    • 2.1.6 Regional trends

Chapter 3 Electrocardiogram (ECG) Devices Industry Insights

  • 3.1 Industry landscape, 2018 - 2032 (USD Million)
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Growing prevalence of cardiovascular diseases
      • 3.2.1.2 Rising elderly population
      • 3.2.1.3 Technological advancements in ECG devices
      • 3.2.1.4 Increasing adoption of mobile and telemetry cardiac monitors
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High cost of advanced ECG devices
      • 3.2.2.2 Lack of skilled professionals
  • 3.3 Growth potential analysis
    • 3.3.1 By product
    • 3.3.2 By lead type
    • 3.3.3 By portability
    • 3.3.4 By end-use
  • 3.4 COVID-19 impact analysis
  • 3.5 Regulatory landscape
    • 3.5.1 U.S.
    • 3.5.2 Europe
  • 3.6 Reimbursement scenario
  • 3.7 Technology landscape
    • 3.7.1 Upcoming technologies
  • 3.8 Porter's analysis
  • 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2021

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Strategy dashboard

Chapter 5 Electrocardiogram (ECG) Devices Market, By Product

  • 5.1 Key product trends
  • 5.2 Diagnostic ECG machines
    • 5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.2.2 Market estimates and forecast, 2018 - 2032 ('000 Units)
    • 5.2.3 Resting ECG
      • 5.2.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
      • 5.2.3.2 Market estimates and forecast, 2018 - 2032 ('000 Units)
    • 5.2.4 Stress ECG
      • 5.2.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
      • 5.2.4.2 Market estimates and forecast, 2018 - 2032 ('000 Units)
  • 5.3 Monitoring ECG devices
    • 5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.3.2 Market estimates and forecast, 2018 - 2032 ('000 Units)
    • 5.3.3 Holter monitor
      • 5.3.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
      • 5.3.3.2 Market estimates and forecast, 2018 - 2032 ('000 Units)
    • 5.3.4 Implantable cardiac monitors
      • 5.3.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
      • 5.3.4.2 Market estimates and forecast, 2018 - 2032 ('000 Units)
    • 5.3.5 ECG telemetry monitoring / event monitoring
      • 5.3.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
      • 5.3.5.2 Market estimates and forecast, 2018 - 2032 ('000 Units)
    • 5.3.6 Others
      • 5.3.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
      • 5.3.6.2 Market estimates and forecast, 2018 - 2032 ('000 Units)

Chapter 6 Electrocardiogram (ECG) Devices Market, By Lead Type

  • 6.1 Key lead type trends
  • 6.2 Single lead type
    • 6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 6.3 3-lead type
    • 6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 6.4 6- lead type
    • 6.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 6.5 12- lead type
    • 6.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 6.6 Others
    • 6.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 7 Electrocardiogram (ECG) Devices Market, By Portability

  • 7.1 Key portability trends
  • 7.2 Portable device
    • 7.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 7.2.2 Market estimates and forecast, 2018 - 2032 ('000 Units)
  • 7.3 Non-portable device
    • 7.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 7.3.2 Market estimates and forecast, 2018 - 2032 ('000 Units)

Chapter 8 Electrocardiogram (ECG) Devices Market, By End-use

  • 8.1 Key end-use trends
  • 8.2 Hospitals & clinics
    • 8.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 8.3 Diagnostic centers
    • 8.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 8.4 Ambulatory surgical centers
    • 8.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 8.5 Homecare settings
    • 8.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 8.6 Others
    • 8.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 9 Electrocardiogram (ECG) Devices Market, By Region

  • 9.1 Key regional trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Italy
    • 9.3.5 Spain
    • 9.3.6 Poland
    • 9.3.7 Switzerland
    • 9.3.8 Netherlands
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Thailand
    • 9.4.7 Indonesia
  • 9.5 Latin America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Columbia
    • 9.5.4 Mexico
  • 9.6 MEA
    • 9.6.1 Saudi Arabia
    • 9.6.2 South Africa
    • 9.6.3 Israel
    • 9.6.4 UAE

Chapter 10 Company Profiles

  • 10.1 AliveCor, Inc.
  • 10.2 Allengers Medical Systems, Ltd.
  • 10.3 Biotricity, Inc.
  • 10.4 Bionet America, Inc.
  • 10.5 Biotronik SE & Co. KG
  • 10.6 Boston Scientific Corporation
  • 10.7 BPL Medical Technologies
  • 10.8 Cardioline S.P.A
  • 10.9 Fukuda Denshi Co., Ltd.
  • 10.10 GE Healthcare
  • 10.11 Hill-Rom Holdings, Inc. (Baxter)
  • 10.12 Koninklijke Philips N.V.
  • 10.13 Medtronic plc
  • 10.14 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 10.15 Spacelabs Healthcare (OSI Systems, Inc.)